Activity value 76india Buyer&Supplier,Last transaction date:
2026-02-08
Overview
Export data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for r.m.pharma co from 2025 to 2026.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2026, the company has completed 5 transactions, with a transaction quantity of 94060 and a transaction weight of 0.
YearTransactionsQuantityWeight
2025409673490
20265940600
Bill of lading data
<
1/15
>
Trade date
2026/02/08
B/L No.
7108482
Suppliers
r.m.pharma co
Buyers
.pharmaplus s.a.r.l.
POLs
sonepat
PODs
matadi
Supply area
India
Purchas area
The Democratic Republic Of The Congo
Weight
——
Amount
763591.57
Hs code
30049099
Product tags
pharmaceutical,bat,x 100,suspension,alu,fg f
Product description
PHARMACEUTICALS GOODS PALUDROX 100ML SUSPENSION BATCH NO RMJ 541A MFG FEB 25 EXP JAN 28
Expand
Trade date
2026/02/08
B/L No.
2743361
Suppliers
r.m.pharma co
Buyers
.pharmaplus s.a.r.l.
POLs
sonepat
PODs
matadi
Supply area
India
Purchas area
The Democratic Republic Of The Congo
r.m.pharma co is india Buyer&Supplier,
and primarily engages in the import and export business of products such as pharmaceutical,bat,syrup.
According to the 52wmb.com global trade database, as of 2026-02-08, the company has completed 1076 international trades,
with its main trading regions covering the democratic republic of the congo,the republic of congo,nigeria etc.
The core products include HS30049099,HS30046000,HS30042019 etc,
often transported via delhi,port nhava sheva sea innsa1, port sonepat icd etc,
and its main trading partners are .pharmaplus s.a.r.l.,pharma plus s.a.r..l bakongo n 19,g,eden u.k pharmaceuticals ltd..
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on r.m.pharma co is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.